BCOP Updates 2025: Updates in Carcinoma of Unknown Primary

Type: Individual•Format: On-demand

Carcinomas of unknown primary are uncommon but can pose treatment challenges for providers and confer a poor prognosis for the patients. Chemotherapy options are limited and typically chosen based on pathological findings. Molecular profiling and use of next-generation sequencing can help guide therapy in some cases. This update will review current treatment recommendations.

BCOP Updates 2025: Updates in Carcinoma of Unknown Primary

Author: Isabel Houlzet, PharmD, BCOP

Learning Objectives

  1. Review carcinoma of unknown primary (CUP) and recommended systemic treatment options based on tumor histology
  2. Describe the role of molecular profiling in CUP and its potential impact in care
  3. Interpret recent clinical trial data for tumor-agonistic indications in treating patients with select tumor markers
  4. Demonstrate the importance of multidisciplinary and individualized care for this patient population

Get it now!

Knowledge Course for Pharmacists

Technology requirements: HOPA Learn requires a modern web browser (Internet Explorer 7+, Mozilla Firefox, Apple Safari, Google Chrome) and the ability to listen to audio with the content.

acpe-bps-logos

HOPA is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. In order to claim BCOP credit, you must pass the BCOP Post-Test with a 75% or higher.

All CE hours will be transmitted to the CPE Monitor and BPS within 1-2 weeks of course completion.